Chemokines in hyperthyroidism
Silvia Martina Ferrari, Ilaria Ruffilli, Giusy Elia and 6 more
Journal of Clinical & Translational Endocrinology · 2019
doi:10.1016/j.jcte.2019.100196 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The term “hyperthyroidism” indicates a condition due to an exaggerate production of thyroid hormone; the most frequent cause is Graves’ disease (GD).We review cytokines and chemokines in hyperthyroidism, with a special focus in GD.In GD, recruited Th1 lymphocytes are responsible for enhanced IFN-γ and TNF-α production, which in turn stimulates Th1 chemokines release from thyrocytes, initiating and perpetuating the autoimmune process.Circulating levels of these chemokines are associated with the active phase of GD.Additional studies are necessary to investigate whether Th1 chemokines could be a novel therapeutic target in this disease. Keywords: Chemokines, Cytokines, Hyperthyroidism, Graves’ disease, CXCL10, CXCL9
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.